Pharmaceutical Articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Hundreds of Risperdal gynecomastia lawsuits filed in Philadelphia court

Posted: August 29, 2014

About 700 product liability lawsuits involving the antipsychotic Risperdal have been filed in Philadelphia Court of Common Pleas alleging use of the drug caused boys and young men to develop breasts, a condition referred to as gynecomastia. Many of the

Drug company testing type 2 diabetes drug designed to have fewer side effects

Posted: August 29, 2014

Drug developer BioKier currently testing a new oral formulation of type 2 diabetes treatment that may prove safer than injectable versions of the drug currently on the market.

Regeneron, Sanofi pay $67.5 million to expedite approval of experimental cholesterol drug

Posted: August 29, 2014

Regeneron Pharmaceuticals and Sanofi are paying $67.5 million to improve the chances of getting their experimental cholesterol-lowering drug on the market before any other drug company with similar cholesterol treatments in development. Regeneron and Sanofi are purchasing a first-of-its-kind voucher

Novel new diabetes treatment fares well in clinical trials

Posted: August 27, 2014

Clinical trials on a novel new type 2 diabetes treatment lowered glucose, did not increase lipids, and was well tolerated in patients with the chronic disease.

Lipitor side effects lawsuits mount against Pfizer

Posted: August 27, 2014

Lawsuits are mounting against Pfizer Inc., alleging the company withheld information that its cholesterol-lowering statin drug Lipitor could cause women to develop type 2 diabetes. In the past five months, Lipitor side effects lawsuits have jumped from 56 to more than

Newborn head and body support products recalled due to presence of mold

Posted: August 26, 2014

Children’s Medical Ventures is recalling its Gel-E Donut and Squishon 2 products used in hospitals to support and cradle an infant’s head or body because of numerous complaints about visible mold on the outer surface of the products. The mold

Mirena IUD linked to increased breast cancer risk in premenopausal women

Posted: August 26, 2014

Premenopausal women who use a hormone-releasing intrauterine device, such as the Mirena IUD, are at greater risk of developing breast cancer, according to a study recently published in the journal Obstetrics & Gynecology.

Insulin therapy may help prevent acute pancreatitis

Posted: August 25, 2014

Acute pancreatitis affects about 20,000 people every year and results in 1,000 deaths. It can also increase the risk for pancreatic cancer, one of the most deadly forms of the disease. Yet, there is no immediate cure for the painful and

New testosterone replacement capsule fares well in clinical trials

Posted: August 25, 2014

Clinical trials for Clarus Therapeutic’s new testosterone replacement treatment Rextoro show the drug is comparable to other testosterone therapies and, if approved by the Food and Drug Administration (FDA), could provide patients with yet another treatment option to boost the

Bone marrow treatment restores hair growth in patients with alopecia

Posted: August 24, 2014

Clinical trials on FDA-approved drugs for other conditions have been shown to restore hair growth in some patients with alopecia areata, an autoimmune disease that causes hair loss.